Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2849]

Immunotherapy for leukaemia may affect the bone marrow environment, cancer researchers find

Immunotherapy for leukaemia may affect the bone marrow environment, cancer researchers find

Cabozantinib approved in the EU for previously treated advanced neuroendocrine tumours

Cabozantinib approved in the EU for previously treated advanced neuroendocrine tumours

$Belantamab mafodotin combinations approved in EU for treatment of relapsed/refractory multiple myeloma$

Belantamab mafodotin combinations approved in EU for treatment of relapsed/refractory multiple myeloma

‘Powerful new approach’: New drug combination strategy shows promise against hard-to-treat cancers

‘Powerful new approach’: New drug combination strategy shows promise against hard-to-treat cancers

Less is more: Low-dose olanzapine curbs chemo-induced nausea without the sedation

Less is more: Low-dose olanzapine curbs chemo-induced nausea without the sedation

New strategy doubles chemo effectiveness in treatment-resistant cancer

New strategy doubles chemo effectiveness in treatment-resistant cancer

Novel one-two punch treatment strategy shows promise in preclinical models of advanced prostate cancer

Novel one-two punch treatment strategy shows promise in preclinical models of advanced prostate cancer

Cholesterol-lowering drugs show promise against colorectal cancer

Cholesterol-lowering drugs show promise against colorectal cancer

GALECTIN-3: a biomarker and therapeutic target in pancreatic adenocarcinoma

GALECTIN-3: a biomarker and therapeutic target in pancreatic adenocarcinoma

Temozolomide and radiation treatment lead to dramatic tumour shrinkage and improvement of hearing in an adult brainstem glioma patient with a rare IDH2 mutation

Temozolomide and radiation treatment lead to dramatic tumour shrinkage and improvement of hearing in an adult...

More from ecancer